▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Todd Campbell

XMFEBCapital

@ebcapital

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Recent Articles by Todd Campbell

businessman with binoculars GettyImages-668103054

Aug 2, 2018 by Todd Campbell

What Blueprint Medicines Just Said About Its Future

Investors flocked to the clinical-stage biotech following an encouraging second-quarter update.

IF_healthcare

Aug 1, 2018 by Todd Campbell

Here's What's Going On at Eli Lilly and GlaxoSmithKline

It’s big pharma week! First, we discuss Eli Lilly’s second-quarter earnings and its decision to spin off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company 23andMe.

young_woman_question_marks_GettyImages-476562658

Jul 31, 2018 by Todd Campbell

Is Opko Health Getting Its Mojo Back?

Investor optimism appears to be rebounding following a string of disappointments that caused a sharp decline in share prices.

MARKET RALLY YOUNG MAN WITH MONEY FALLING GettyImages-619229198

Jul 31, 2018 by Todd Campbell

Why Tandem Diabetes Care Is Rallying by 11.3% Today

The insulin pump maker's second-quarter financials are sparking optimism.

GettyImages-462557763

Jul 29, 2018 by Todd Campbell

Can Celgene’s Most Important Drugs Keep Growing?

Here's why the company's top-selling drugs could continue driving this biotech superstar's revenue and profit higher.

senior woman thumbs down GettyImages-518408758

Jul 28, 2018 by Todd Campbell

Social Security's Up 46% Since 2000, So Why Are Retirees Poorer than Ever?

Expenses in retirement are increasing faster than Social Security income, and that's straining seniors' budgets.

medicine with money vertex GettyImages-490802884

Jul 28, 2018 by Todd Campbell, Keith Speights, and Brian Feroldi

3 Top Healthcare Stocks to Buy Right Now

New medicines and technologies could help these healthcare companies deliver market-beating long-term returns.

Market crash man sitting with hands on head GettyImages-864893078

Jul 27, 2018 by Todd Campbell

Here's Why Pacific Biosciences Tumbled 10% Today

Investors are taking a cautious stance ahead of earnings next week and an ongoing trade spat with China.

Jul 25, 2018 by Todd Campbell

Did This Top Biotech Stock Just Go on Sale?

Shares of bluebird bio tumbled sharply on Tuesday, following a decision to tap investors for more money.

senior woman eyes GettyImages-512228792

Jul 24, 2018 by Todd Campbell

Aerie Pharmaceuticals May Revolutionize Glaucoma Treatment

The company's establishing itself as a leader in this growing, multibillion-dollar indication.

earnings GettyImages-579765290

Jul 23, 2018 by Todd Campbell

Here's Why Reata Pharmaceuticals Skyrocketed 65% Today

A drug targeting a rare form of chronic kidney disease is fueling investor's optimism.

business person worried GettyImages-474577567

Jul 23, 2018 by Todd Campbell

Are You Making This Huge Retirement Mistake?

A surprisingly large number of people are making a big blunder when it comes to saving for retirement.

time money balance GettyImages-903545230

Jul 21, 2018 by Todd Campbell

If You're Switching Jobs, Here's What You Should Ask About Their Retirement Plan

Making sure your future employer offers the best 401(k) or 403(b) plan possible may be key to a financially secure future.

Jul 20, 2018 by Todd Campbell

What's Behind PTC Therapeutics' 10% Rally Today

The company's making an acquisition to bulk up its pipeline of clinical-stage drugs.

World Diabetes Day Getty

Jul 20, 2018 by Todd Campbell

Eli Lilly Scores a Win in Diabetes

A new study may give sales of one of its diabetes drugs a boost.

STETHOSCOPE ON PIGGY BANK GettyImages-163931017

Jul 20, 2018 by Todd Campbell, Keith Speights, and Brian Feroldi

3 Top Healthcare Stocks to Buy in July

New products, bigger markets, and market-moving news could cause shares in these three companies to rally.

ACCOUNTANT GettyImages-518433706

Jul 19, 2018 by Todd Campbell

Why MiMedx Group Shares Skyrocketed 18% Today

The hope that a C-suite shake-up and restated financials will put the company's worst days behind it are fueling a rally.

IF_healthcare

Jul 19, 2018 by Todd Campbell

These Epilepsy Drugmakers Are About to Brawl

A new spin on an old drug could dent demand for Epidiolex, a marijuana-based epilepsy drug. Plus, here's how important Medicare and Medicaid are to UnitedHealth Group's profits.

dividend stocks GettyImages-687446530

Jul 17, 2018 by Todd Campbell

What's Behind Johnson & Johnson's Double-Digit Growth?

Currency and acquisition tailwinds aside, the company has a slate of fast-growing drugs in its quiver.

insurance GettyImages-515605078

Jul 17, 2018 by Todd Campbell

UnitedHealth's Business Continues to Grow

The nation's biggest health insurance company continues to rack up revenue and profits.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services